Similarly, two of the identified genes in the current study (SLC14A1 and KIF26B) were identified in an intestinal stem cell signature previously reported to be associated with poor clinical outcome in CRC [20]. The gene discussed is SLC14A1; the disease is colorectal carcinoma.